Spinal muscular atrophy in the disease-modifying therapy era: successes, limitations and future directions

Madison M. Sexton, Emma W. Crow, Congyue Annie Peng

Open source

DOI
10.3389/fmmed.2026.1901311
Published
2026-08-25
Container
Frontiers in Molecular Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmmed.2026.1901311,
  title = {Spinal muscular atrophy in the disease-modifying therapy era: successes, limitations and future directions},
  author = {Madison M. Sexton and Emma W. Crow and Congyue Annie Peng},
  year = {2026},
  journal = {Frontiers in Molecular Medicine},
  doi = {10.3389/fmmed.2026.1901311},
  url = {https://doi.org/10.3389/fmmed.2026.1901311}
}

RIS

TY  - JOUR
TI  - Spinal muscular atrophy in the disease-modifying therapy era: successes, limitations and future directions
AU  - Madison M. Sexton
AU  - Emma W. Crow
AU  - Congyue Annie Peng
PY  - 2026
JO  - Frontiers in Molecular Medicine
DO  - 10.3389/fmmed.2026.1901311
UR  - https://doi.org/10.3389/fmmed.2026.1901311
ER  - 

APA

Sexton, M. M., Crow, E. W., & Peng, C. A. (2026). Spinal muscular atrophy in the disease-modifying therapy era: successes, limitations and future directions. Frontiers in Molecular Medicine. https://doi.org/10.3389/fmmed.2026.1901311

Source records